VOA常速英语2020--特朗普政府拒绝权力交接,疫苗分发遇阻（在线收听）

This is VOA news. Via remote, I'm Jim Bertel.U.S. projected President-elect Joe Biden is expressing frustration about U.S. President Donald Trump's refusal to cooperate on the White House transition process. AP's Sagar Meghani has more. Among other things, the Trump administration is not sharing its coronavirus vaccine distribution plans. Biden says his team needs them. "More people may die if we don't coordinate.” After remarks focused on repairing the nation's economy, Biden told reporters a key step is getting a vaccine to all Americans - a massive undertaking. "If we have to wait until January 20 to start that planning, it puts us behind over a month, month and a half.” He says a vaccine is of little use until people are actually vaccinated. Sagar Meghani, Washington.

下载.jpg这里是美国之音新闻。我是吉姆·博特尔，为您进行远程播报。美国总统唐纳德·特朗普拒绝协助白宫权力交接，美国预计当选总统乔·拜登对此表示非常失望。请听美联社的萨加尔·梅加尼为您进行详细报道。其中，特朗普政府并未分享其冠状病毒疫苗分发计划。拜登表示，他的团队需要这些计划。“如果我们做不到协调一致，会有更多的人死去。”在集中讨论修复美国经济之后，拜登告诉记者，关键在于要为所有美国人接种疫苗，这是一项艰巨的任务。“如果我们要等到1月20日才开展这项计划，那将使我们落后超过一个月、一个半月。”他说，在人们真正接种疫苗之前，疫苗几乎毫无用处。萨加尔·梅加尼，华盛顿报道。

U.S. biotech firm Moderna on Monday announced its experimental vaccine against COVID-19. It is almost 95 percent effective, marking a second major breakthrough in the quest to end the pandemic. AP's Mike Hempen has more. Moderna says preliminary data from an ongoing study show its vaccine is nearly 95 percent effective. Last week, Pfizer announced its own COVID-19 vaccine appears similarly effective. Both companies are now on track to seek permission within weeks for emergency use in the U.S. Virus cases in the country topped 11 million over the weekend. Moderna President Dr. Stephen Hoge says having similar results from two different companies is most reassuring. Hoge says it's going to require many vaccines to meet global demand. I'm Mike Hempen. Meanwhile, the World Health Organization's chief scientist says they find the news about Moderna vaccine to be encouraging. "It appears that the vaccine actually has a protective efficacy of over 90 percent. It's about 94 percent. Of course we need to wait and see what the final efficacy and the safety profile of this vaccine will be ....” She says she remains optimistic the WHO will be (able to) work with many manufacturers to have a wide selection of vaccines as part of its global distribution plan.

美国生物技术公司Moderna周一宣布了其针对新冠肺炎研发的实验性疫苗。它有接近95%的有效性，这标志着在探求疫情结束方面的第二个重大突破。请听美联社的迈克·海姆普为您进行详细报道。Moderna公司表示，一项正在进行的研究的初步数据显示，其疫苗的有效率接近95%。上周，辉瑞公司宣布其自制的新冠肺炎疫苗有相似的有效性。这两家公司目前正准备在数周内向美国申请紧急使用授权。上周末，美国的新冠肺炎感染病例超过1100万例。Moderna公司总裁斯蒂芬·霍格博士表示，两家不同公司研制疫苗的有效性结果相似，这是最让人宽慰的。霍格表示，还需要大量的疫苗以满足全球需求。我是迈克·海姆普。与此同时，世界卫生组织首席科学家说，Moderna疫苗的相关消息鼓舞人心。“看来这种疫苗实际上有90%以上的保护效力。大约在94%。当然，我们还需要拭目以待，看看这种疫苗的最终疗效和安全性如何……”她